{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:15:55Z","timestamp":1767665755177},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T00:00:00Z","timestamp":1488931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council Taiwan","doi-asserted-by":"publisher","award":["NSC-98-2314-B-182-034-MY2","NSC 98-2314-B-182-056","NSC 100-2314-B-182-003","NSC-100-2314-B-182-038"],"award-info":[{"award-number":["NSC-98-2314-B-182-034-MY2","NSC 98-2314-B-182-056","NSC 100-2314-B-182-003","NSC-100-2314-B-182-038"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG390792","CMRPG3C0611","CMRPG3C0612"],"award-info":[{"award-number":["CMRPG390792","CMRPG3C0611","CMRPG3C0612"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"The Ministry of Health and Welfare Taiwan","doi-asserted-by":"publisher","award":["MOHW 104-TDU-B-212-113003, MOHW 105-TDU-B-212-113020, MOHW106-TDU-B-212-113005"],"award-info":[{"award-number":["MOHW 104-TDU-B-212-113003, MOHW 105-TDU-B-212-113020, MOHW106-TDU-B-212-113005"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","jfma-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jfma.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T02:31:27Z","timestamp":1492741887000},"page":"964-972","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dual-phase 18 F-florbetapir positron emission tomography in patients with primary progressive aphasia, Alzheimer's disease, and healthy controls: A preliminary study"],"prefix":"10.1016","volume":"116","author":[{"given":"Hung-Chou","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ing-Tsung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Ju","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu-Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Lun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yau-Yau","family":"Wai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Li","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Ping","family":"Kung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chuan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Chen","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2017.03.003_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ncpneuro0746","article-title":"Clinical course of neuropathologically confirmed frontal-variant Alzheimer's disease","volume":"4","author":"Taylor","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.jfma.2017.03.003_bib2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jfma.2017.03.003_bib3","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","article-title":"Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on frontotemporal dementia and Pick's disease","volume":"58","author":"McKhann","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jfma.2017.03.003_bib4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1212\/01.WNL.0000052685.09194.39","article-title":"Staging disease severity in pathologically confirmed cases of frontotemporal dementia","volume":"60","author":"Broe","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jfma.2017.03.003_bib5","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jfma.2017.03.003_bib6","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1212\/WNL.0b013e31821ccd3c","article-title":"Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia","volume":"76","author":"Rogalski","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jfma.2017.03.003_bib7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.21451","article-title":"Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia","volume":"64","author":"Rabinovici","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jfma.2017.03.003_bib8","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1093\/brain\/awr216","article-title":"Subtypes of progressive aphasia: application of the international consensus criteria and validation using \u03b2-amyloid imaging","volume":"134","author":"Leyton","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jfma.2017.03.003_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fnagi.2011.00010","article-title":"Combined imaging markers dissociate Alzheimer's disease and frontotemporal lobar degeneration\u2014an ALE meta-analysis","volume":"3","author":"Schroeter","year":"2011","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.jfma.2017.03.003_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2017.03.003_bib11","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","article-title":"Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease","volume":"68","author":"Fleisher","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jfma.2017.03.003_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nucmedbio.2010.02.003","article-title":"Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent\u2014a pilot study","volume":"37","author":"Lin","year":"2010","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.jfma.2017.03.003_bib13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In\u00a0vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jfma.2017.03.003_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00259-011-2051-2","article-title":"Correlation of early-phase 18F-florbetapir (AV-45\/Amyvid) PET images to FDG images: preliminary studies","volume":"39","author":"Hsiao","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jfma.2017.03.003_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.91","article-title":"Primary progressive aphasia","volume":"49","author":"Mesulam","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jfma.2017.03.003_bib16","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra022435","article-title":"Primary progressive aphasia: a language-based dementia","volume":"349","author":"Mesulam","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2017.03.003_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jfma.2017.03.003_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/jnnp.2010.209122","article-title":"APOE epsilon4 increases the risk of progression from amnestic mild cognitive impairment to Alzheimer's disease among ethnic Chinese in Taiwan","volume":"82","author":"Wang","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jfma.2017.03.003_bib19","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.apradiso.2010.07.001","article-title":"GMP-compliant automated synthesis of [18F]AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain","volume":"8","author":"Yao","year":"2010","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.jfma.2017.03.003_bib20","doi-asserted-by":"crossref","first-page":"e58974","DOI":"10.1371\/journal.pone.0058974","article-title":"Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2017.03.003_bib21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00259-013-2350-x","article-title":"Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45\/Amyvid) PET","volume":"40","author":"Hsiao","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jfma.2017.03.003_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuroimage.2009.01.057","article-title":"Reducing between scanner differences in multi-center PET studies","volume":"46","author":"Joshi","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.jfma.2017.03.003_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jns.2012.04.014","article-title":"Amyloid deposition after cerebral hypoperfusion: evidenced on [18F]AV-45 positron emission tomography","volume":"319","author":"Huang","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jfma.2017.03.003_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.jfma.2017.03.003_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00259-007-0523-1","article-title":"In\u00a0vivo amyloid imaging with PET in frontotemporal dementia","volume":"35","author":"Engler","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jfma.2017.03.003_bib26","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/01.wnl.0000259035.98480.ed","article-title":"11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration","volume":"68","author":"Rabinovici","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jfma.2017.03.003_bib27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.21388","article-title":"Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia","volume":"63","author":"Mesulam","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jfma.2017.03.003_bib28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.neuroimage.2007.03.024","article-title":"Towards a nosology for frontotemporal lobar degenerations-a meta-analysis involving 267 subjects","volume":"36","author":"Schroeter","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.jfma.2017.03.003_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/jnnp.2005.075341","article-title":"Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease","volume":"77","author":"van de Pol","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jfma.2017.03.003_bib30","doi-asserted-by":"crossref","first-page":"e18111","DOI":"10.1371\/journal.pone.0018111","article-title":"Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia","volume":"6","author":"Dukart","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2017.03.003_bib31","first-page":"233","article-title":"18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients","volume":"46","author":"Jeong","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jfma.2017.03.003_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2967\/jnumed.110.082057","article-title":"Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients","volume":"52","author":"Rostomian","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jfma.2017.03.003_bib33","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3233\/JAD-2010-100222","article-title":"Clinically different stages of Alzheimer's disease associated by amyloid deposition with [11C]-PIB PET imaging","volume":"21","author":"Hatashita","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jfma.2017.03.003_bib34","first-page":"385","article-title":"Phase 1 trials on florbetaben brain PET in elderly normal controls","volume":"51","author":"Barthel","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jfma.2017.03.003_bib35","first-page":"1754","article-title":"Ethnic comparability of safety and pharmacokinetics of florbetaben (BAY 94-9172) in normal Caucasian and Asian subjects","volume":"51","author":"Senda","year":"2010","journal-title":"J Nucl Med"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664617301869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664617301869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T19:08:00Z","timestamp":1658948880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664617301869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0929664617301869"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2017.03.003","relation":{},"ISSN":["0929-6646"],"issn-type":[{"type":"print","value":"0929-6646"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-phase 18F-florbetapir positron emission tomography in patients with primary progressive aphasia, Alzheimer's disease, and healthy controls: A preliminary study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}